RHO and neoplasm: Pharmacological inhibition of downstream factors such as Arp2/3, a major regulator of actin assembly and migration, may block RHO signaling regardless of the upstream oncogenic alterations or signals from the tumor microenvironment that may induce the pathway, and restrict metastatic dissemination.